GLP-1RAs and cardiovascular risk reduction in hidradenitis suppurativa: A real-world cohort study

By afschroeder • July 24, 2025

Chou PP, Jeong C, Ma E, Roberts AM, Katz A, Nong Y, Yan MJ, Johnsen N, Armstrong AW. GLP-1RAs and cardiovascular risk reduction in hidradenitis suppurativa: A real-world cohort study. J Eur Acad Dermatol Venereol. 2025 Jul 22. doi: 10.1111/jdv.20874. Epub ahead of print. PMID: 40693677.

Tags: cardiovascular disease, Dermatology, diabetes mellitus, glucagon‐like peptide‐1 receptor, hidradenitis suppurativa, metabolic disease, Obesity, Publications

Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials

Alexis AF, Kircik L, Chovatiya R, Rice ZP, Soong W, Bhutani T, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM, Armstrong AW. Tapinarof Cream for[...]

Emergency versus Outpatient Care for Pediatric Atopic Dermatitis: A Population-Based Study of Sociodemographic Factors and Health Care Utilization

Yamamoto RK, Tolson HC, Hao A, Kikuchi R, Sadrolashrafi K, Guo L, Bilimoria SN, Yee D, Armstrong AW. Emergency versus Outpatient Care for Pediatric Atopic[...]

Recurrent and Infiltrative Basal Cell Carcinoma of the Nose After High-Dose Rate Electronic Brachytherapy

Park A, Castillo J. Recurrent and Infiltrative Basal Cell Carcinoma of the Nose After High-Dose Rate Electronic Brachytherapy. Dermatol Surg. 2025 Jul 15. doi: 10.1097/DSS.0000000000004773.[...]